RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Auris Medical Holding Stock

Auris Medical Holding Market capitalization 2024

Auris Medical Holding Market capitalization

6.25 M CHF

Ticker

EARS

ISIN

BMG070252017

WKN

A2PJN3

In 2024, Auris Medical Holding's market cap stood at 6.25 M CHF, a -64% increase from the 17.35 M CHF market cap in the previous year.

The Auris Medical Holding Market capitalization history

YEARMarket Capitalization (undefined CHF)
20206.59
201912.07
201821.54
201723.56
20164.31
20150.71
20140.67
2013-
2012-

Auris Medical Holding Aktienanalyse

What does Auris Medical Holding do?

Auris Medical Holding Ltd is a biopharmaceutical company that was founded in 2013 and is headquartered in Zug, Switzerland. The company specializes in the development and marketing of products in the field of hearing and hearing impairment. The history of Auris Medical Holding Ltd began with the founding of the company by Thomas Meyer and Daniel J. Salomon, both of whom had extensive experience in the biotech industry and investment banking. The company went public on the NASDAQ stock exchange in 2014 and has since expanded its business steadily. Auris Medical's business model is based on the development of innovative therapies and medications for disorders in the ENT field. The company focuses on the needs of patients with hearing and hearing impairment due to neurosensory disorders. In this area, there are currently only a few approved therapies, which represents a significant unmet medical need. Auris Medical divides its activities into two divisions: the development of clinical therapies and the marketing of products for the treatment of tinnitus and hearing loss. In the field of clinical therapies, the company specializes in the development of medications for restoring hearing. Among other things, Auris Medical is working on the development of AM-111, a treatment for acute inner ear damage that can lead to sudden hearing loss. Auris Medical also operates its own distribution chain, which offers products for the treatment of tinnitus and hearing loss. These products are marketed under the name Tinnitool and include devices for relieving tinnitus and hearing loss. The company also offers audiology services to perform individual audiological evaluations. Overall, Auris Medical Holding Ltd has a wide range of products aimed at the needs of patients with hearing and hearing impairment. From medications to symptom relief products to diagnostic services, the company is able to address various aspects of the health issue. As an innovative company, Auris Medical Holding Ltd invests heavily in research and development of new therapies and medications. The company collaborates with leading experts in the field of hearing and hearing impairment to improve its technologies and products. Additionally, the company aims to expand into further regions to reach a broader patient base. In summary, Auris Medical Holding Ltd is an emerging company in the field of hearing and hearing impairment. With a wide product portfolio tailored to the needs of patients, the company invests in research and development to develop new therapies and medications. Through its innovation and strong partnerships in the field of hearing and hearing impairment, the company plans to establish itself as a leading company in this field. Auris Medical Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Auris Medical Holding's Market Capitalization

Auris Medical Holding's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Auris Medical Holding's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Auris Medical Holding's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Auris Medical Holding’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Auris Medical Holding stock

What is the current Auris Medical Holding market capitalization?

The current market capitalization of Auris Medical Holding is 6.25 M CHF.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Auris Medical Holding.

How has the market capitalization of Auris Medical Holding developed in recent years?

The market capitalization of Auris Medical Holding has increased/decreased by -64% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Auris Medical Holding?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Auris Medical Holding?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Auris Medical Holding have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Auris Medical Holding pay?

Over the past 12 months, Auris Medical Holding paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Auris Medical Holding is expected to pay a dividend of 0 CHF.

What is the dividend yield of Auris Medical Holding?

The current dividend yield of Auris Medical Holding is .

When does Auris Medical Holding pay dividends?

Auris Medical Holding pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Auris Medical Holding?

Auris Medical Holding paid dividends every year for the past 0 years.

What is the dividend of Auris Medical Holding?

For the upcoming 12 months, dividends amounting to 0 CHF are expected. This corresponds to a dividend yield of 0 %.

In which sector is Auris Medical Holding located?

Auris Medical Holding is assigned to the 'Health' sector.

Wann musste ich die Aktien von Auris Medical Holding kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Auris Medical Holding from 9/21/2024 amounting to 0 CHF, you needed to have the stock in your portfolio before the ex-date on 9/21/2024.

When did Auris Medical Holding pay the last dividend?

The last dividend was paid out on 9/21/2024.

What was the dividend of Auris Medical Holding in the year 2023?

In the year 2023, Auris Medical Holding distributed 0 CHF as dividends.

In which currency does Auris Medical Holding pay out the dividend?

The dividends of Auris Medical Holding are distributed in CHF.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Auris Medical Holding

Our stock analysis for Auris Medical Holding Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Auris Medical Holding Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.